[HTML][HTML] New therapies for advanced thyroid cancer
D Laha, N Nilubol, M Boufraqech - Frontiers in endocrinology, 2020 - frontiersin.org
Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …
[HTML][HTML] Anaplastic thyroid carcinoma: an update
Simple Summary Anaplastic thyroid carcinoma (ATC) has a dismal prognostic.
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …
Chemotherapy and radiotherapy are the mainstem options for patients with ATC. In selected …
2021 American thyroid association guidelines for management of patients with anaplastic thyroid cancer: American thyroid association anaplastic thyroid cancer …
KC Bible, E Kebebew, J Brierley, JP Brito… - Thyroid, 2021 - liebertpub.com
Background: Anaplastic thyroid cancer (ATC) is a rare but highly lethal form of thyroid
cancer. Since the guidelines for the management of ATC by the American Thyroid …
cancer. Since the guidelines for the management of ATC by the American Thyroid …
Combination of lenvatinib and pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Background: Anaplastic thyroid carcinoma (ATC) and metastatic poorly differentiated thyroid
carcinomas (PDTCs) are rare aggressive malignancies with poor overall survival (OS) …
carcinomas (PDTCs) are rare aggressive malignancies with poor overall survival (OS) …
[HTML][HTML] Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics
L Lu, JR Wang, YC Henderson, S Bai… - The Journal of …, 2023 - Am Soc Clin Investig
The deadliest anaplastic thyroid cancer (ATC) often transforms from indolent differentiated
thyroid cancer (DTC); however, the complex intratumor transformation process is poorly …
thyroid cancer (DTC); however, the complex intratumor transformation process is poorly …
Genomic alterations in thyroid cancer: biological and clinical insights
I Landa, ME Cabanillas - Nature Reviews Endocrinology, 2024 - nature.com
Tumours can arise from thyroid follicular cells if they acquire driver mutations that
constitutively activate the MAPK signalling pathway. In addition, a limited set of additional …
constitutively activate the MAPK signalling pathway. In addition, a limited set of additional …
Anaplastic thyroid cancer: An update
SN Rao, RC Smallridge - Best Practice & Research Clinical Endocrinology …, 2023 - Elsevier
Anaplastic thyroid cancer (ATC) is one of the most lethal of all cancers. It is more common in
women and occurs primarily in older patients. ATC has a median overall survival of 3–5 …
women and occurs primarily in older patients. ATC has a median overall survival of 3–5 …
Anaplastic thyroid carcinoma: Current issues in genomics and therapeutics
I Abe, AK Lam - Current Oncology Reports, 2021 - Springer
Abstract Purpose of Review Anaplastic thyroid carcinoma is a type of thyroid carcinoma with
the most aggressive biological behaviour amongst thyroid cancer. Here, we review the …
the most aggressive biological behaviour amongst thyroid cancer. Here, we review the …
Mechanistic insights of thyroid cancer progression
LJ Leandro-García, I Landa - Endocrinology, 2023 - academic.oup.com
Differentiated thyroid cancers (DTCs) are primarily initiated by mutations that activate the
MAPK signaling cascade, typically at BRAF or RAS oncoproteins. DTCs can evolve to more …
MAPK signaling cascade, typically at BRAF or RAS oncoproteins. DTCs can evolve to more …
Diagnosis and management of anaplastic thyroid cancer
AV Chintakuntlawar, RL Foote… - Endocrinology and …, 2019 - endo.theclinics.com
Anaplastic thyroid cancer (ATC) is an extremely aggressive but rare form of thyroid
malignancy, making up only 1% to 2% of all thyroid cancers. 1 Although the incidence of …
malignancy, making up only 1% to 2% of all thyroid cancers. 1 Although the incidence of …